Ablacon
Wheat Ridge
About Ablacon
Ablacon has built a premier machine intelligence system to quantitatively and qualitatively understand and treat atrial fibrillation (AF).Their technology visualizes in real-time what is going on in the heart. They compute the electrographic flow which allows to treat atrial fibrillation faster, more precisely and more reliably.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $63.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2021)
- Website: ablacon.com
- Phone: +1 (303) 955-5620
Industries & Categories
Artificial Intelligence (AI), Machine Learning, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/ablacon-84201 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.